Abstract:Cyclic dinucleotides (CDNs) are known to activate stimulator of interferon genes (STING) and induce type I interferon responses, therefor possess great potentials to be of immunotherapeutic value for cancers and infectious diseases. However, the existence of different single nucleotide polymorphism (SNP) of human STING (hSTING) gene poses an obstacle to achieve broad-spectrum activation by CDNs. We reported here the design and synthesis of a total of 36 CDNs, representing all structural variations, that contain four bases (A, G, C, U) and two linkage directions (2′-5′-linked and 3′-5′-linked phosphodiester). Through systematic evaluation of IFN-β induction with a dual-luciferase reporter assay, we discovered that wild type hSTING and two isoforms (HAQ and AQ) showed strong response while hSTING-R232H and R293Q exhibited the relatively weak response to CDNs stimulation. For the first time, we found that the c[G(2′,5′)U(2′,5′)] showed excellent activity against all five hSTING variants even equivalent to the endogenous ligand c[G(2′,5′)A(3′,5′)]. Furthermore, we have also demonstrated that 3′-3′ CDNs with two 3′-5′ phosphodiesters showed higher serum and hydrolase stability than 2′-2′ CDNs with two 2′-5′ phosphodiesters and 2′-3′ CDNs with one 2′-5′ and one 3′-5′ phosphodiester. It is very interesting to note that 2′-2′ CDNs has been found for the first time to show strong activity. These findings will stimulate our exploration for the new functional role of CDNs, and provide guidelines to design CDNs based hSTING targeted drugs.

Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

CDNs-STING Interaction Mechanism Investigations and Instructions on Design of CDN-Derivatives.

Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

Synthesis of All Possible Canonical (3 '-5 '-Linked) Cyclic Dinucleotides and Evaluation of Riboswitch Interactions and Immune-Stimulatory Effects

Computational and NMR Spectroscopy Insights into the Conformation of Cyclic Di-Nucleotides.

Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein

Structure of STING Bound to Cyclic Di-Gmp Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System

Design, Synthesis and Systematic Evaluation of All Possible Cyclic Dinucleotides (cdns) That Activate Human Stimulator of Interferon Genes (STING) Variants

Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design

Chemical Synthesis, Purification, and Characterization of 3′-5′-linked Canonical Cyclic Dinucleotides (Cdns)

Detection of Cyclic Dinucleotides by STING.

Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING

Crystal Structures of STING Protein Reveal Basis for Recognition of Cyclic Di-Gmp

2',4'‐LNA‐Functionalized 5′‐S‐phosphorothioester CDNs as STING agonist

Cgas Facilitates Sensing of Extracellular Cyclic Dinucleotides to Activate Innate Immunity

The Structural Basis for the Sensing and Binding of Cyclic Di-Gmp by STING.

Unraveling the Binding Mode of Cyclic Adenosine–Inosine Monophosphate (cAIMP) to STING through Molecular Dynamics Simulations

2 ',3 '-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis

Arabinose- and xylose-modified analogs of 2',3'-cGAMP act as STING agonists

Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants